BridgeBio ^Companies

BridgeBio is a biotechnology company that focuses on the development and commercialization of precision medicines for various genetic diseases and cancers. Their main goal is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases. They bridge advancements in genetic science to patients with unmet needs through their entrepreneurial engine. BridgeBio's achievements include designing transformative medicines for patients with genetic diseases and turning scientific discoveries into patient solutions as quickly as possible.